SENNOSIDES

SENNOSIDES was reported 30370 times

SENNOSIDES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY VASCULITIS 168 0.3123
1 TOTAL LUNG CAPACITY ABNORMAL 103 0.2648
2 CAPILLARITIS 64 0.2319
3 BURKHOLDERIA TEST POSITIVE 22 0.1774
4 SPIROMETRY ABNORMAL 98 0.1639
5 MITE ALLERGY 97 0.1481
6 TEMPERATURE REGULATION DISORDER 276 0.1238
7 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 84 0.1146
8 MYCOTIC ALLERGY 97 0.1135
9 NEURITIS 170 0.1100
10 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 96 0.1036
11 DUST ALLERGY 98 0.0999
12 CONJUNCTIVITIS ALLERGIC 105 0.0709
13 SOFT TISSUE MASS 32 0.0693
14 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 134 0.0657
15 RESPIRATORY SYMPTOM 179 0.0629
16 POSTMORTEM BLOOD DRUG LEVEL INCREASED 23 0.0617
17 TOTAL LUNG CAPACITY DECREASED 88 0.0551
18 FOOD ALLERGY 365 0.0472
19 FOETAL DEATH 242 0.0466
20 CREATININE RENAL CLEARANCE INCREASED 34 0.0455
21 CLOSTRIDIUM TEST POSITIVE 94 0.0426
22 MULTIPLE DRUG THERAPY 32 0.0424
23 OESOPHAGEAL PERFORATION 32 0.0384
24 PLEURITIC PAIN 103 0.0373
25 FORCED EXPIRATORY VOLUME DECREASED 103 0.0363
26 LUNG OPACITY 95 0.0360
27 NORMOCHROMIC NORMOCYTIC ANAEMIA 107 0.0356
28 NEUROLOGICAL SYMPTOM 186 0.0325
29 PULMONARY ALVEOLAR HAEMORRHAGE 177 0.0315
30 MULTIMORBIDITY 34 0.0284
31 SUPERINFECTION 40 0.0266
32 IMMUNODEFICIENCY 389 0.0261
33 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 27 0.0254
34 OBSTRUCTIVE AIRWAYS DISORDER 275 0.0247
35 RALES 138 0.0237
36 BLOOD ALKALINE PHOSPHATASE ABNORMAL 21 0.0233
37 COELIAC DISEASE 228 0.0232
38 ARTERIOSCLEROSIS CORONARY ARTERY 152 0.0229
39 SEDATION COMPLICATION 57 0.0223
40 BURSITIS 247 0.0203
41 LUNG CONSOLIDATION 56 0.0200
42 NEPHROGENIC ANAEMIA 86 0.0185
43 PRESCRIBED OVERDOSE 350 0.0181
44 NEUTROPENIC SEPSIS 127 0.0178
45 CLEFT PALATE 33 0.0171
46 VASCULITIS 196 0.0168
47 FULL BLOOD COUNT ABNORMAL 171 0.0162
48 PULMONARY FIBROSIS 300 0.0156
49 ASPIRATION 168 0.0153
50 BRONCHIECTASIS 101 0.0150
51 PNEUMONIA ASPIRATION 372 0.0149
52 HYPERPARATHYROIDISM SECONDARY 37 0.0148
53 PNEUMONIA VIRAL 47 0.0147
54 CREATININE RENAL CLEARANCE DECREASED 59 0.0147
55 TRANSPLANT FAILURE 35 0.0143
56 ARTERIOSCLEROSIS 134 0.0142
57 SPUTUM DISCOLOURED 131 0.0138
58 HAEMOPTYSIS 382 0.0137
59 ESCHERICHIA BACTERAEMIA 32 0.0136
60 ATRIAL TACHYCARDIA 28 0.0133
61 BLOOD CALCIUM INCREASED 116 0.0132
62 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 42 0.0127
63 NEUTROPHIL COUNT INCREASED 129 0.0126
64 HOSPICE CARE 124 0.0125
65 ANTIPSYCHOTIC DRUG LEVEL INCREASED 35 0.0124
66 FEBRILE NEUTROPENIA 801 0.0121
67 HYPOXIA 420 0.0119
68 CANCER PAIN 30 0.0117
69 BREATH SOUNDS ABNORMAL 57 0.0115
70 EOSINOPHIL COUNT DECREASED 27 0.0113
71 HYPERPHOSPHATAEMIA 24 0.0112
72 FAECALOMA 61 0.0111
73 PRURITUS GENITAL 26 0.0110
74 DECUBITUS ULCER 89 0.0109
75 COMA SCALE ABNORMAL 31 0.0107
76 UPPER RESPIRATORY TRACT INFECTION 488 0.0106
77 FAILURE TO THRIVE 54 0.0104
78 RENAL FUNCTION TEST ABNORMAL 48 0.0103
79 STOMA SITE DISCHARGE 28 0.0102
80 ATELECTASIS 97 0.0100
81 METABOLIC ENCEPHALOPATHY 30 0.0100
82 METHAEMOGLOBINAEMIA 23 0.0099
83 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 168 0.0099
84 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 50 0.0099
85 VOLVULUS 23 0.0097
86 CARBOHYDRATE ANTIGEN 125 INCREASED 33 0.0097
87 BLOOD TEST ABNORMAL 133 0.0095
88 GASTROINTESTINAL HYPOMOTILITY 21 0.0093
89 CONTRAINDICATED PRODUCT ADMINISTERED 281 0.0093
90 SPINAL CORD COMPRESSION 36 0.0092
91 HYPONATRAEMIA 520 0.0092
92 LOWER RESPIRATORY TRACT INFECTION 418 0.0092
93 ORTHOSTATIC HYPOTENSION 158 0.0091
94 CONSTIPATION 1976 0.0091
95 HYPERNATRAEMIA 45 0.0090
96 NEUTROPHIL COUNT ABNORMAL 25 0.0088
97 NODULE 115 0.0088
98 BLOOD PHOSPHORUS DECREASED 32 0.0087
99 EXFOLIATIVE RASH 23 0.0087
100 BLOOD MAGNESIUM DECREASED 74 0.0086
101 AORTIC ARTERIOSCLEROSIS 22 0.0085
102 MENTAL STATUS CHANGES 236 0.0085
103 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 28 0.0084
104 UROSEPSIS 78 0.0084
105 SMALL INTESTINAL OBSTRUCTION 104 0.0084
106 ILEUS PARALYTIC 37 0.0083
107 FEMORAL NECK FRACTURE 42 0.0082
108 CLOSTRIDIUM DIFFICILE COLITIS 86 0.0081
109 FREEZING PHENOMENON 30 0.0081
110 BLOOD CALCIUM DECREASED 91 0.0081
111 PROTEIN TOTAL DECREASED 30 0.0080
112 ILEUS 98 0.0079
113 PLEURAL EFFUSION 471 0.0077
114 PANCREATIC CARCINOMA METASTATIC 22 0.0077
115 MULTIPLE MYELOMA 36 0.0077
116 RED CELL DISTRIBUTION WIDTH INCREASED 32 0.0077
117 PULMONARY MASS 114 0.0076
118 END STAGE RENAL DISEASE 139 0.0076
119 HYDRONEPHROSIS 57 0.0076
120 GLOSSITIS 27 0.0076
121 FLUID RETENTION 383 0.0075
122 TROPONIN INCREASED 57 0.0075
123 ENDOTRACHEAL INTUBATION 21 0.0075
124 LEFT VENTRICULAR DYSFUNCTION 50 0.0075
125 RHINOVIRUS INFECTION 29 0.0074
126 CAROTID ARTERY OCCLUSION 27 0.0074
127 RASH ERYTHEMATOUS 350 0.0073
128 URINE OUTPUT DECREASED 64 0.0073
129 PATHOLOGICAL FRACTURE 37 0.0073
130 OESOPHAGEAL ULCER 28 0.0073
131 COMPRESSION FRACTURE 39 0.0073
132 BLOOD CREATININE ABNORMAL 25 0.0072
133 HYPOVOLAEMIA 42 0.0072
134 HYPOTHYROIDISM 226 0.0071
135 POSTURE ABNORMAL 23 0.0071
136 HICCUPS 58 0.0071
137 INFLAMMATORY MARKER INCREASED 35 0.0071
138 POST-TRAUMATIC STRESS DISORDER 47 0.0070
139 INFUSION RELATED REACTION 463 0.0070
140 MALNUTRITION 77 0.0069
141 HEPATIC ENZYME INCREASED 468 0.0069
142 LYMPHOCYTE COUNT DECREASED 121 0.0068
143 ON AND OFF PHENOMENON 38 0.0068
144 DUODENITIS 21 0.0068
145 UPPER GASTROINTESTINAL HAEMORRHAGE 115 0.0068
146 HYPOPHOSPHATAEMIA 50 0.0068
147 METASTATIC NEOPLASM 29 0.0067
148 HAEMATOCRIT DECREASED 132 0.0066
149 BONE LESION 24 0.0066
150 WHEEZING 393 0.0066
151 MONOCYTE COUNT INCREASED 24 0.0066
152 ESCHERICHIA URINARY TRACT INFECTION 28 0.0066
153 BACTERAEMIA 78 0.0066
154 DELIRIUM 228 0.0066
155 SPINAL COMPRESSION FRACTURE 54 0.0065
156 HYPERVOLAEMIA 32 0.0065
157 BLOOD ALBUMIN DECREASED 51 0.0064
158 URINARY RETENTION 213 0.0064
159 APLASTIC ANAEMIA 33 0.0063
160 HYPOPHAGIA 161 0.0063
161 IRON DEFICIENCY ANAEMIA 58 0.0063
162 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27 0.0062
163 DROOLING 43 0.0062
164 DECREASED IMMUNE RESPONSIVENESS 61 0.0062
165 PRODUCTIVE COUGH 296 0.0062
166 UNRESPONSIVE TO STIMULI 160 0.0062
167 LIVER FUNCTION TEST INCREASED 133 0.0062
168 HALLUCINATIONS, MIXED 26 0.0062
169 CARDIOMEGALY 76 0.0062
170 GASTROINTESTINAL MOTILITY DISORDER 33 0.0062
171 HAEMORRHOIDS 120 0.0061
172 ASTHMA 691 0.0061
173 LIVER FUNCTION TEST ABNORMAL 177 0.0061
174 LARGE INTESTINE PERFORATION 42 0.0060
175 CARDIAC MURMUR 52 0.0060
176 PNEUMOTHORAX 95 0.0060
177 RENAL FAILURE CHRONIC 46 0.0060
178 GASTROOESOPHAGEAL REFLUX DISEASE 481 0.0060
179 SLEEP TERROR 25 0.0059
180 HYPERKALAEMIA 208 0.0059
181 CIRCULATORY COLLAPSE 101 0.0059
182 TRANSFUSION 62 0.0059
183 FAECES HARD 23 0.0059
184 HEPARIN-INDUCED THROMBOCYTOPENIA 29 0.0059
185 NEUTROPHIL COUNT DECREASED 239 0.0059
186 CELLULITIS 295 0.0058
187 TRANSAMINASES INCREASED 129 0.0058
188 MYOCARDIAL ISCHAEMIA 66 0.0058
189 BLOOD SODIUM DECREASED 109 0.0058
190 VASCULAR DEVICE INFECTION 26 0.0057
191 SEPSIS 638 0.0057
192 RENAL TUBULAR NECROSIS 56 0.0057
193 DUODENAL ULCER 40 0.0057
194 EXPOSURE DURING PREGNANCY 352 0.0057
195 EJECTION FRACTION DECREASED 88 0.0057
196 BRADYKINESIA 33 0.0056
197 INTERNATIONAL NORMALISED RATIO INCREASED 159 0.0056
198 BLOOD CREATININE INCREASED 361 0.0055
199 OESOPHAGEAL CANDIDIASIS 22 0.0055
200 ELECTROLYTE IMBALANCE 64 0.0055
201 SINUS TACHYCARDIA 78 0.0055
202 LUNG DISORDER 268 0.0055
203 MYOSITIS 49 0.0055
204 HYPOMAGNESAEMIA 76 0.0055
205 PNEUMONIA BACTERIAL 50 0.0054
206 ASCITES 160 0.0054
207 SUPRAVENTRICULAR TACHYCARDIA 52 0.0054
208 THROMBOCYTOPENIA 606 0.0054
209 FAECAL INCONTINENCE 26 0.0054
210 SUBARACHNOID HAEMORRHAGE 55 0.0054
211 ABSCESS LIMB 23 0.0054
212 NEUROLEPTIC MALIGNANT SYNDROME 64 0.0054
213 HUMERUS FRACTURE 26 0.0054
214 ACUTE RESPIRATORY FAILURE 103 0.0053
215 WHITE BLOOD CELL COUNT INCREASED 205 0.0053
216 FLANK PAIN 50 0.0053
217 TOXIC ENCEPHALOPATHY 27 0.0053
218 HYPOALBUMINAEMIA 41 0.0053
219 MUCOSAL INFLAMMATION 138 0.0053
220 HAEMOGLOBIN INCREASED 24 0.0053
221 TRISMUS 27 0.0052
222 NON-SMALL CELL LUNG CANCER 25 0.0052
223 PLATELET COUNT INCREASED 68 0.0052
224 ABDOMINAL ABSCESS 23 0.0052
225 INCONTINENCE 55 0.0052
226 ENTEROCOCCAL INFECTION 25 0.0052
227 HAEMOGLOBIN ABNORMAL 33 0.0051
228 ACUTE KIDNEY INJURY 785 0.0051
229 TENSION HEADACHE 22 0.0051
230 DEHYDRATION 679 0.0051
231 ORAL CANDIDIASIS 67 0.0051
232 PULMONARY EMBOLISM 478 0.0050
233 FLUID OVERLOAD 73 0.0050
234 DRUG LEVEL INCREASED 83 0.0050
235 HAEMORRHAGIC ANAEMIA 22 0.0050
236 DEPRESSED LEVEL OF CONSCIOUSNESS 198 0.0050
237 FAECES DISCOLOURED 108 0.0050
238 LUNG INFILTRATION 44 0.0050
239 HALLUCINATION 375 0.0050
240 DELUSION 77 0.0050
241 BLOOD ALKALINE PHOSPHATASE INCREASED 123 0.0049
242 HYPERHIDROSIS 638 0.0049
243 CATATONIA 26 0.0049
244 HYPOKALAEMIA 228 0.0049
245 RESPIRATORY FAILURE 360 0.0049
246 HAEMATEMESIS 125 0.0049
247 GENERALISED OEDEMA 61 0.0049
248 RENAL FAILURE ACUTE 209 0.0049
249 ORAL PAIN 110 0.0049
250 SALIVARY HYPERSECRETION 49 0.0049
251 WRONG PRODUCT ADMINISTERED 33 0.0049
252 FULL BLOOD COUNT DECREASED 98 0.0049
253 MYOCLONUS 58 0.0049
254 MUSCLE RIGIDITY 58 0.0048
255 SEDATION 127 0.0048
256 PNEUMONITIS 132 0.0048
257 HAEMOGLOBIN DECREASED 496 0.0048
258 LUMBAR VERTEBRAL FRACTURE 22 0.0048
259 MYOCARDITIS 55 0.0048
260 LETHARGY 276 0.0048
261 URINARY TRACT INFECTION 816 0.0048
262 ANAL INCONTINENCE 43 0.0048
263 INTENTIONAL PRODUCT MISUSE 418 0.0048
264 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 229 0.0048
265 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 248 0.0047
266 BLOOD LACTIC ACID INCREASED 25 0.0047
267 DYSARTHRIA 178 0.0047
268 RETCHING 100 0.0047
269 PROCTALGIA 30 0.0047
270 STAPHYLOCOCCAL SEPSIS 23 0.0047
271 LEUKOCYTOSIS 84 0.0046
272 PLASMA CELL MYELOMA 181 0.0046
273 OEDEMA PERIPHERAL 565 0.0046
274 ABDOMINAL TENDERNESS 23 0.0046
275 PLATELET COUNT DECREASED 491 0.0046
276 LOWER GASTROINTESTINAL HAEMORRHAGE 34 0.0046
277 URINE ODOUR ABNORMAL 27 0.0046
278 PARTIAL SEIZURES 24 0.0046
279 CONFUSIONAL STATE 739 0.0046
280 BOWEL MOVEMENT IRREGULARITY 35 0.0046
281 RED BLOOD CELL COUNT DECREASED 130 0.0045
282 HALLUCINATION, VISUAL 96 0.0045
283 WHITE BLOOD CELL COUNT ABNORMAL 29 0.0045
284 COMA 216 0.0045
285 CLOSTRIDIUM DIFFICILE INFECTION 99 0.0045
286 PRESYNCOPE 110 0.0045
287 HYPERLIPIDAEMIA 54 0.0045
288 ATRIAL FLUTTER 36 0.0045
289 CYTOKINE RELEASE SYNDROME 90 0.0045
290 BLOOD UREA INCREASED 75 0.0045
291 BODY TEMPERATURE DECREASED 44 0.0045
292 MUSCLE TWITCHING 103 0.0045
293 PERIPHERAL VASCULAR DISORDER 23 0.0045
294 HYPERCALCAEMIA 55 0.0044
295 ADRENAL INSUFFICIENCY 54 0.0044
296 DYSPHAGIA 422 0.0044
297 FEELING DRUNK 33 0.0044
298 REFUSAL OF TREATMENT BY PATIENT 29 0.0044
299 BLOOD POTASSIUM INCREASED 72 0.0044
300 RIB FRACTURE 91 0.0044
301 VENTRICULAR TACHYCARDIA 73 0.0044
302 BLOOD PRESSURE SYSTOLIC INCREASED 86 0.0044
303 EOSINOPHILIA 77 0.0044
304 OESOPHAGITIS 48 0.0044
305 GASTRITIS 115 0.0044
306 MELAENA 96 0.0044
307 PNEUMONIA 1412 0.0044
308 CARDIAC FAILURE ACUTE 29 0.0043
309 SUBDURAL HAEMATOMA 62 0.0043
310 BLADDER DISORDER 43 0.0043
311 RESPIRATORY RATE INCREASED 38 0.0043
312 ANAEMIA 814 0.0043
313 HAEMATURIA 146 0.0043
314 BENIGN PROSTATIC HYPERPLASIA 22 0.0043
315 PYREXIA 1474 0.0043
316 MITRAL VALVE INCOMPETENCE 48 0.0042
317 ECCHYMOSIS 29 0.0042
318 FLUID INTAKE REDUCED 21 0.0042
319 NEURALGIA 102 0.0042
320 ODYNOPHAGIA 25 0.0042
321 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
322 ACIDOSIS 32 0.0042
323 INTESTINAL PERFORATION 47 0.0042
324 JOINT SWELLING 504 0.0042
325 DEEP VEIN THROMBOSIS 271 0.0042
326 TRICUSPID VALVE INCOMPETENCE 33 0.0041
327 GLOMERULAR FILTRATION RATE DECREASED 51 0.0041
328 CHOLECYSTITIS 49 0.0041
329 SPINAL OSTEOARTHRITIS 36 0.0041
330 TASTE DISORDER 83 0.0041
331 OSTEOMYELITIS 74 0.0041
332 CACHEXIA 21 0.0041
333 WHITE BLOOD CELL COUNT DECREASED 440 0.0041
334 LYMPHOEDEMA 28 0.0040
335 MICTURITION URGENCY 46 0.0040
336 BACK PAIN 931 0.0040
337 INTESTINAL OBSTRUCTION 151 0.0040
338 DRUG INTOLERANCE 386 0.0040
339 NEUROTOXICITY 70 0.0040
340 DISEASE PROGRESSION 472 0.0040
341 ENTEROCOLITIS 23 0.0040
342 TUMOUR LYSIS SYNDROME 35 0.0040
343 ATAXIA 47 0.0040
344 TOXIC EPIDERMAL NECROLYSIS 60 0.0039
345 SCHIZOPHRENIA 48 0.0039
346 FALL 1313 0.0039
347 RECTAL HAEMORRHAGE 168 0.0039
348 PANCYTOPENIA 218 0.0039
349 DECREASED INTEREST 23 0.0039
350 ELECTROCARDIOGRAM QT PROLONGED 140 0.0039
351 BLOOD BILIRUBIN INCREASED 105 0.0039
352 NEUTROPENIA 528 0.0039
353 CHOLECYSTITIS ACUTE 22 0.0039
354 MUSCULOSKELETAL CHEST PAIN 60 0.0039
355 COGNITIVE DISORDER 181 0.0039
356 CHOLANGITIS 24 0.0039
357 ACUTE CORONARY SYNDROME 32 0.0039
358 HYPERTENSION 818 0.0039
359 BLOOD POTASSIUM DECREASED 116 0.0039
360 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 274 0.0038
361 DECREASED APPETITE 890 0.0038
362 HYPERGLYCAEMIA 139 0.0038
363 URINARY INCONTINENCE 113 0.0038
364 INFUSION SITE SWELLING 24 0.0038
365 MOUTH SWELLING 22 0.0038
366 CHRONIC KIDNEY DISEASE 289 0.0038
367 DYSKINESIA 153 0.0038
368 ALANINE AMINOTRANSFERASE INCREASED 231 0.0038
369 BALANCE DISORDER 325 0.0038
370 GROIN PAIN 33 0.0038
371 HYPOTENSION 752 0.0037
372 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 33 0.0037
373 PSEUDOMONAS INFECTION 32 0.0037
374 DIZZINESS POSTURAL 36 0.0037
375 POSTOPERATIVE WOUND INFECTION 25 0.0037
376 FACIAL PAIN 33 0.0037
377 POLYP 24 0.0037
378 RESPIRATORY DISTRESS 101 0.0037
379 DIVERTICULUM 26 0.0037
380 GINGIVAL PAIN 29 0.0036
381 THROMBOSIS 293 0.0036
382 FACIAL PARALYSIS 31 0.0036
383 PULMONARY OEDEMA 162 0.0036
384 EMBOLISM 30 0.0036
385 CANDIDA INFECTION 61 0.0036
386 HEAD INJURY 114 0.0036
387 PELVIC FRACTURE 28 0.0036
388 JOINT DISLOCATION 38 0.0036
389 HYPOCALCAEMIA 68 0.0036
390 GASTROINTESTINAL HAEMORRHAGE 300 0.0036
391 ENCEPHALOPATHY 88 0.0036
392 TUBULOINTERSTITIAL NEPHRITIS 67 0.0036
393 CARDIAC FAILURE CONGESTIVE 287 0.0036
394 EMPHYSEMA 36 0.0036
395 RIGHT VENTRICULAR FAILURE 25 0.0036
396 WOUND INFECTION 39 0.0036
397 MOUTH HAEMORRHAGE 26 0.0035
398 HIP FRACTURE 114 0.0035
399 HAEMORRHAGE INTRACRANIAL 53 0.0035
400 DIPLOPIA 92 0.0035
401 TREATMENT FAILURE 293 0.0035
402 BLOOD LACTATE DEHYDROGENASE INCREASED 56 0.0035
403 ABDOMINAL PAIN 822 0.0035
404 TRANSIENT ISCHAEMIC ATTACK 119 0.0035
405 DENTAL CARIES 39 0.0035
406 SINUS BRADYCARDIA 34 0.0035
407 SEPTIC SHOCK 153 0.0035
408 CYTOPENIA 43 0.0035
409 MUSCLE SPASTICITY 43 0.0035
410 TACHYCARDIA 310 0.0035
411 RENAL IMPAIRMENT 293 0.0035
412 BACTERIAL INFECTION 65 0.0035
413 PARANOIA 60 0.0035
414 EOSINOPHIL COUNT INCREASED 29 0.0035
415 STOMATITIS 211 0.0035
416 COVID-19 PNEUMONIA 41 0.0035
417 APNOEA 27 0.0035
418 VENTRICULAR EXTRASYSTOLES 36 0.0035
419 LEUKOPENIA 173 0.0035
420 AGITATION 254 0.0035
421 INTERVERTEBRAL DISC DEGENERATION 32 0.0035
422 PEMPHIGOID 26 0.0034
423 HEPATIC STEATOSIS 64 0.0034
424 COLITIS 130 0.0034
425 DERMATITIS CONTACT 39 0.0034
426 JAUNDICE 92 0.0034
427 INFUSION SITE PAIN 44 0.0034
428 METASTASES TO LIVER 60 0.0034
429 METASTASES TO BONE 56 0.0034
430 COLITIS ISCHAEMIC 23 0.0034
431 ATRIAL FIBRILLATION 332 0.0034
432 DEMENTIA 95 0.0034
433 BRADYCARDIA 180 0.0034
434 LIPASE INCREASED 26 0.0034
435 MYELODYSPLASTIC SYNDROME 49 0.0034
436 PARKINSONISM 33 0.0034
437 HYPOGLYCAEMIA 164 0.0034
438 METASTASES TO LUNG 39 0.0034
439 RESTLESS LEGS SYNDROME 61 0.0034
440 SOMNOLENCE 673 0.0033
441 DYSURIA 123 0.0033
442 ACUTE MYELOID LEUKAEMIA 52 0.0033
443 PULMONARY HAEMORRHAGE 26 0.0033
444 CHROMATURIA 75 0.0033
445 LARGE INTESTINE POLYP 23 0.0033
446 MENTAL IMPAIRMENT 80 0.0033
447 MUSCULAR WEAKNESS 375 0.0033
448 BLOOD COUNT ABNORMAL 50 0.0033
449 NOCTURIA 40 0.0033
450 HALLUCINATION, AUDITORY 52 0.0033
451 GENERAL PHYSICAL HEALTH DETERIORATION 377 0.0033
452 PSYCHIATRIC SYMPTOM 24 0.0032
453 DEVICE RELATED INFECTION 50 0.0032
454 OEDEMA 176 0.0032
455 HYPERSOMNIA 93 0.0032
456 PYELONEPHRITIS 28 0.0032
457 ALTERED STATE OF CONSCIOUSNESS 70 0.0032
458 SEIZURE 372 0.0032
459 SKIN LACERATION 35 0.0032
460 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
461 SKIN ULCER 83 0.0032
462 EPISTAXIS 239 0.0032
463 MALIGNANT NEOPLASM PROGRESSION 327 0.0032
464 DYSPNOEA EXERTIONAL 120 0.0032
465 NEUROPATHY PERIPHERAL 303 0.0032
466 VITAMIN D DEFICIENCY 31 0.0032
467 OSTEOPENIA 48 0.0032
468 GASTRIC ULCER 60 0.0032
469 ASPARTATE AMINOTRANSFERASE INCREASED 167 0.0031
470 ASTHENIA 1181 0.0031
471 OXYGEN SATURATION DECREASED 176 0.0031
472 DYSPNOEA 1771 0.0031
473 CHEST PAIN 579 0.0031
474 MYOPATHY 27 0.0031
475 DIFFUSE LARGE B-CELL LYMPHOMA 24 0.0031
476 PERICARDIAL EFFUSION 72 0.0031
477 MOBILITY DECREASED 223 0.0031
478 SPINAL FRACTURE 62 0.0031
479 SLEEP APNOEA SYNDROME 59 0.0031
480 LUNG INFECTION 48 0.0031
481 BODY TEMPERATURE INCREASED 63 0.0031
482 PAIN IN JAW 87 0.0031
483 MULTIPLE ALLERGIES 24 0.0031
484 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
485 VOMITING 1438 0.0031
486 BLOOD CREATINE PHOSPHOKINASE INCREASED 88 0.0031
487 TREMOR 506 0.0030
488 ESCHERICHIA INFECTION 25 0.0030
489 STAPHYLOCOCCAL INFECTION 100 0.0030
490 POST PROCEDURAL COMPLICATION 58 0.0030
491 HAEMODYNAMIC INSTABILITY 23 0.0030
492 RASH MACULO-PAPULAR 67 0.0030
493 MASS 42 0.0030
494 COAGULOPATHY 50 0.0030
495 HEPATIC ENCEPHALOPATHY 28 0.0030
496 BLOOD DISORDER 24 0.0030
497 BODY HEIGHT DECREASED 32 0.0030
498 ABDOMINAL DISTENSION 312 0.0030
499 CHOLELITHIASIS 98 0.0030
500 PULMONARY HYPERTENSION 62 0.0030
501 DIALYSIS 42 0.0030
502 BLOOD IRON DECREASED 35 0.0029
503 LIP SWELLING 98 0.0029
504 PURPURA 26 0.0029
505 HIATUS HERNIA 38 0.0029
506 PARALYSIS 42 0.0029
507 ABNORMAL FAECES 24 0.0029
508 INFECTION 423 0.0029
509 GASTROINTESTINAL PAIN 32 0.0029
510 HYPERSENSITIVITY 539 0.0029
511 DYSPHONIA 169 0.0029
512 PRODUCT USE ISSUE 543 0.0029
513 DRUG INTERACTION 458 0.0029
514 PERIPHERAL SWELLING 444 0.0029
515 PETECHIAE 30 0.0029
516 FATIGUE 2228 0.0029
517 GLOSSODYNIA 64 0.0029
518 JOINT INJURY 61 0.0029
519 ACUTE MYOCARDIAL INFARCTION 84 0.0028
520 TOOTH ABSCESS 29 0.0028
521 THERAPY CHANGE 28 0.0028
522 EXOSTOSIS 26 0.0028
523 CARDIAC ARREST 235 0.0028
524 DEVICE OCCLUSION 40 0.0028
525 CARDIOMYOPATHY 42 0.0028
526 GENERALISED TONIC-CLONIC SEIZURE 47 0.0028
527 SUDDEN DEATH 30 0.0028
528 HEART RATE IRREGULAR 64 0.0028
529 ULCER 45 0.0028
530 SEASONAL ALLERGY 40 0.0028
531 PRODUCT ADMINISTRATION INTERRUPTED 22 0.0028
532 BRAIN INJURY 28 0.0028
533 WEIGHT DECREASED 779 0.0028
534 DRUG TOXICITY 38 0.0028
535 STEVENS-JOHNSON SYNDROME 62 0.0028
536 GOUT 50 0.0028
537 WEIGHT FLUCTUATION 29 0.0028
538 RENAL CYST 22 0.0028
539 SPEECH DISORDER 145 0.0028
540 LACERATION 26 0.0028
541 SKIN INFECTION 31 0.0028
542 OVERDOSE 591 0.0027
543 BEDRIDDEN 36 0.0027
544 MANIA 45 0.0027
545 ATRIOVENTRICULAR BLOCK 21 0.0027
546 ANOREXIA 35 0.0027
547 CONCUSSION 21 0.0027
548 FEEDING DISORDER 55 0.0027
549 BLOOD PRESSURE FLUCTUATION 65 0.0027
550 RHEUMATOID ARTHRITIS 307 0.0027
551 CYSTITIS 86 0.0027
552 NIGHT SWEATS 87 0.0027
553 SYNCOPE 270 0.0027
554 RENAL FAILURE 356 0.0027
555 PERICARDITIS 45 0.0027
556 HYPERAESTHESIA 22 0.0027
557 APPENDICITIS 25 0.0027
558 BACK INJURY 29 0.0027
559 C-REACTIVE PROTEIN INCREASED 97 0.0027
560 MOTOR DYSFUNCTION 27 0.0026
561 BLOOD URINE PRESENT 50 0.0026
562 NAUSEA 2078 0.0026
563 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45 0.0026
564 COLON CANCER 39 0.0026
565 BLOOD PRESSURE INCREASED 400 0.0026
566 RHABDOMYOLYSIS 109 0.0026
567 VENTRICULAR FIBRILLATION 29 0.0026
568 RESPIRATORY TRACT INFECTION 68 0.0026
569 INFUSION SITE ERYTHEMA 22 0.0026
570 HYPERBILIRUBINAEMIA 27 0.0026
571 GASTROENTERITIS VIRAL 47 0.0026
572 MYASTHENIA GRAVIS 21 0.0026
573 TENDERNESS 27 0.0026
574 HYPERCHOLESTEROLAEMIA 25 0.0026
575 DRUG-INDUCED LIVER INJURY 81 0.0026
576 MUSCULOSKELETAL STIFFNESS 226 0.0026
577 SLEEP DISORDER 182 0.0026
578 CONTUSION 248 0.0026
579 WOUND 72 0.0026
580 CORONARY ARTERY DISEASE 78 0.0026
581 TACHYPNOEA 35 0.0026
582 HEPATIC FUNCTION ABNORMAL 96 0.0026
583 CEREBRAL HAEMORRHAGE 92 0.0026
584 BONE PAIN 150 0.0026
585 APHASIA 77 0.0025
586 BLISTER 143 0.0025
587 INTERNAL HAEMORRHAGE 29 0.0025
588 BRAIN OEDEMA 32 0.0025
589 LOCALISED INFECTION 61 0.0025
590 ABDOMINAL PAIN UPPER 519 0.0025
591 IRRITABLE BOWEL SYNDROME 54 0.0025
592 CARDIAC FAILURE 202 0.0025
593 HEART RATE INCREASED 249 0.0025
594 PERITONITIS 52 0.0025
595 UPPER LIMB FRACTURE 50 0.0025
596 SCIATICA 40 0.0025
597 HAEMATOMA 65 0.0025
598 PAIN 1540 0.0025
599 BRAIN NEOPLASM 23 0.0025
600 DECREASED ACTIVITY 27 0.0025
601 HAEMODIALYSIS 21 0.0025
602 DISORIENTATION 99 0.0025
603 ACUTE RESPIRATORY DISTRESS SYNDROME 44 0.0025
604 MULTI-ORGAN FAILURE 43 0.0025
605 FEMUR FRACTURE 77 0.0025
606 OSTEOARTHRITIS 105 0.0025
607 MOUTH ULCERATION 52 0.0025
608 THIRST 44 0.0025
609 CEREBRAL INFARCTION 60 0.0025
610 HEPATIC FAILURE 74 0.0025
611 GASTROINTESTINAL INFECTION 22 0.0025
612 EPILEPSY 75 0.0025
613 PAIN IN EXTREMITY 722 0.0024
614 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 57 0.0024
615 GAMMA-GLUTAMYLTRANSFERASE INCREASED 54 0.0024
616 DIARRHOEA 1569 0.0024
617 IMPAIRED GASTRIC EMPTYING 33 0.0024
618 CYST 30 0.0024
619 PSORIASIS 315 0.0024
620 SICKLE CELL ANAEMIA WITH CRISIS 38 0.0024
621 COMPLICATION ASSOCIATED WITH DEVICE 35 0.0024
622 PSYCHOTIC DISORDER 71 0.0024
623 METASTASES TO CENTRAL NERVOUS SYSTEM 31 0.0024
624 HYPOAESTHESIA ORAL 36 0.0024
625 OSTEONECROSIS OF JAW 59 0.0024
626 DRY MOUTH 193 0.0024
627 PERITONITIS BACTERIAL 24 0.0024
628 ANGINA PECTORIS 68 0.0024
629 LYMPHADENOPATHY 84 0.0024
630 HYPOTHERMIA 24 0.0024
631 DRUG ERUPTION 42 0.0024
632 SWOLLEN TONGUE 74 0.0024
633 DYSSTASIA 69 0.0024
634 HEADACHE 1481 0.0024
635 RENAL INJURY 70 0.0024
636 PULMONARY CONGESTION 31 0.0023
637 ERYTHEMA 483 0.0023
638 ANOSMIA 34 0.0023
639 EATING DISORDER 50 0.0023
640 ABNORMAL BEHAVIOUR 93 0.0023
641 SEROTONIN SYNDROME 45 0.0023
642 OSTEOPOROSIS 96 0.0023
643 BLOOD PRESSURE DECREASED 155 0.0023
644 DIABETIC KETOACIDOSIS 56 0.0023
645 COUGH 651 0.0023
646 PANCREATITIS ACUTE 52 0.0023
647 DIVERTICULITIS 64 0.0023
648 BASAL CELL CARCINOMA 36 0.0023
649 PHOTOSENSITIVITY REACTION 38 0.0023
650 RESTLESSNESS 84 0.0023
651 GAIT DISTURBANCE 439 0.0023
652 PULMONARY THROMBOSIS 25 0.0023
653 INTERSTITIAL LUNG DISEASE 111 0.0023
654 SWELLING FACE 149 0.0023
655 LIMB INJURY 62 0.0023
656 PULMONARY ARTERIAL HYPERTENSION 33 0.0023
657 TOOTH INFECTION 30 0.0023
658 GRAND MAL CONVULSION 21 0.0023
659 PERIPHERAL COLDNESS 31 0.0023
660 RASH 984 0.0023
661 PRESCRIBED UNDERDOSE 45 0.0023
662 NECK PAIN 126 0.0023
663 FACE OEDEMA 38 0.0023
664 ERYTHEMA MULTIFORME 21 0.0022
665 BONE DISORDER 41 0.0022
666 MIDDLE INSOMNIA 42 0.0022
667 AGEUSIA 56 0.0022
668 HEMIPARESIS 38 0.0022
669 INTERVERTEBRAL DISC PROTRUSION 49 0.0022
670 LOWER LIMB FRACTURE 43 0.0022
671 LABORATORY TEST ABNORMAL 66 0.0022
672 ANXIETY 635 0.0022
673 ORAL DISCOMFORT 31 0.0022
674 SPLENOMEGALY 26 0.0022
675 AGGRESSION 111 0.0022
676 LOSS OF CONSCIOUSNESS 284 0.0022
677 MUSCULOSKELETAL PAIN 116 0.0022
678 HAEMATOCHEZIA 122 0.0022
679 HYPERTHYROIDISM 32 0.0022
680 CONVULSION 126 0.0022
681 RESPIRATORY DEPRESSION 27 0.0022
682 NASAL CONGESTION 129 0.0022
683 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
684 GALLBLADDER DISORDER 39 0.0022
685 TOXICITY TO VARIOUS AGENTS 368 0.0022
686 PRODUCT ADMINISTRATION ERROR 44 0.0022
687 MUSCLE SPASMS 398 0.0022
688 HOSPITALISATION 333 0.0022
689 DYSTONIA 42 0.0022
690 OROPHARYNGEAL PAIN 200 0.0022
691 NEOPLASM PROGRESSION 75 0.0022
692 COORDINATION ABNORMAL 30 0.0021
693 APHONIA 30 0.0021
694 POST PROCEDURAL HAEMORRHAGE 25 0.0021
695 AMNESIA 139 0.0021
696 ABDOMINAL PAIN LOWER 54 0.0021
697 SKIN EXFOLIATION 180 0.0021
698 NO THERAPEUTIC RESPONSE 26 0.0021
699 TENDONITIS 33 0.0021
700 RENAL DISORDER 99 0.0021
701 CHILLS 249 0.0021
702 FLATULENCE 120 0.0021
703 BONE MARROW FAILURE 43 0.0021
704 DYSPEPSIA 208 0.0021
705 MALAISE 927 0.0021
706 HEART RATE DECREASED 74 0.0021
707 ANGIOEDEMA 93 0.0021
708 FUNGAL INFECTION 70 0.0021
709 GAIT INABILITY 70 0.0021
710 DIZZINESS 1044 0.0021
711 HAIR COLOUR CHANGES 26 0.0021
712 CARDIO-RESPIRATORY ARREST 87 0.0021
713 CONDITION AGGRAVATED 632 0.0021
714 RESPIRATORY TRACT CONGESTION 33 0.0021
715 RENAL PAIN 22 0.0021
716 PHOTOPHOBIA 39 0.0021
717 ABSCESS 33 0.0021
718 DERMATITIS ALLERGIC 26 0.0021
719 HYPOKINESIA 30 0.0021
720 SKIN REACTION 29 0.0021
721 FOOT FRACTURE 39 0.0021
722 VIRAL INFECTION 68 0.0020
723 RESPIRATORY DISORDER 61 0.0020
724 POLLAKIURIA 85 0.0020
725 CENTRAL NERVOUS SYSTEM LESION 28 0.0020
726 EYE INFECTION 23 0.0020
727 INSOMNIA 541 0.0020
728 HEPATIC CIRRHOSIS 38 0.0020
729 HERNIA 39 0.0020
730 EXTRAPYRAMIDAL DISORDER 50 0.0020
731 THYROID DISORDER 31 0.0020
732 MEMORY IMPAIRMENT 276 0.0020
733 METABOLIC ACIDOSIS 64 0.0020
734 PROTEINURIA 38 0.0020
735 DEPRESSED MOOD 105 0.0020
736 HERPES ZOSTER 114 0.0020
737 NERVE INJURY 22 0.0020
738 ACUTE HEPATIC FAILURE 27 0.0020
739 BREAST PAIN 21 0.0020
740 PAIN OF SKIN 53 0.0020
741 LIVER DISORDER 87 0.0020
742 TREATMENT NONCOMPLIANCE 107 0.0020
743 TOOTHACHE 35 0.0019
744 RASH PAPULAR 43 0.0019
745 BRONCHITIS 142 0.0019
746 SHOCK 44 0.0019
747 GASTRIC HAEMORRHAGE 22 0.0019
748 DYSGEUSIA 142 0.0019
749 HYPOAESTHESIA 284 0.0019
750 CHOKING 37 0.0019
751 BLOOD GLUCOSE DECREASED 91 0.0019
752 DEATH 1629 0.0019
753 PROSTATIC SPECIFIC ANTIGEN INCREASED 26 0.0019
754 ABDOMINAL DISCOMFORT 315 0.0019
755 GASTROINTESTINAL DISORDER 168 0.0019
756 PALLOR 51 0.0019
757 ANKLE FRACTURE 29 0.0019
758 DISTURBANCE IN ATTENTION 101 0.0019
759 COLD SWEAT 33 0.0019
760 SKIN DISCOLOURATION 86 0.0019
761 SINUS DISORDER 37 0.0019
762 SKIN LESION 51 0.0019
763 PHARYNGITIS 23 0.0019
764 GASTROENTERITIS 27 0.0018
765 ISCHAEMIC STROKE 33 0.0018
766 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
767 RASH PRURITIC 100 0.0018
768 TOOTH DISORDER 41 0.0018
769 IMPAIRED HEALING 60 0.0018
770 PALPITATIONS 214 0.0018
771 SWELLING 171 0.0018
772 BRONCHOSPASM 26 0.0018
773 OBESITY 29 0.0018
774 PANCREATITIS 96 0.0018
775 MENTAL DISORDER 79 0.0018
776 POOR QUALITY SLEEP 39 0.0018
777 HEAD DISCOMFORT 32 0.0018
778 THERAPY PARTIAL RESPONDER 28 0.0018
779 MUSCLE TIGHTNESS 29 0.0018
780 TOOTH EXTRACTION 22 0.0018
781 EYE PAIN 99 0.0018
782 JOINT STIFFNESS 46 0.0018
783 THERAPY CESSATION 90 0.0018
784 MOVEMENT DISORDER 56 0.0017
785 SARS-COV-2 TEST POSITIVE 23 0.0017
786 NEPHROLITHIASIS 79 0.0017
787 BACK DISORDER 28 0.0017
788 AGRANULOCYTOSIS 32 0.0017
789 LACRIMATION INCREASED 52 0.0017
790 THINKING ABNORMAL 32 0.0017
791 JOINT RANGE OF MOTION DECREASED 23 0.0017
792 OFF LABEL USE 1498 0.0017
793 DRUG DISPENSING ERROR 26 0.0017
794 CEREBROVASCULAR ACCIDENT 288 0.0017
795 RASH GENERALISED 44 0.0017
796 HIP ARTHROPLASTY 26 0.0017
797 HOT FLUSH 127 0.0017
798 HEPATITIS 43 0.0017
799 MEDICATION ERROR 93 0.0017
800 CARDIOGENIC SHOCK 24 0.0017
801 BLOOD PRESSURE ABNORMAL 33 0.0017
802 EAR INFECTION 44 0.0017
803 FEELING COLD 46 0.0017
804 THERAPY NON-RESPONDER 74 0.0016
805 CARPAL TUNNEL SYNDROME 23 0.0016
806 FRACTURE 31 0.0016
807 CHEST DISCOMFORT 167 0.0016
808 TARDIVE DYSKINESIA 46 0.0016
809 DRY EYE 80 0.0016
810 COVID-19 281 0.0016
811 BRAIN FOG 25 0.0016
812 SKIN DISORDER 53 0.0016
813 VISION BLURRED 218 0.0016
814 EYE SWELLING 59 0.0016
815 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
816 ECONOMIC PROBLEM 24 0.0016
817 LIMB DISCOMFORT 49 0.0016
818 KIDNEY INFECTION 31 0.0016
819 ABASIA 39 0.0016
820 EYE HAEMORRHAGE 21 0.0016
821 CYTOMEGALOVIRUS INFECTION 26 0.0016
822 ARTHRALGIA 650 0.0016
823 RESPIRATORY ARREST 43 0.0016
824 LYMPHOPENIA 22 0.0016
825 THERAPY INTERRUPTED 111 0.0016
826 EYE PRURITUS 52 0.0015
827 DEPRESSION 349 0.0015
828 SINUSITIS 157 0.0015
829 BONE LOSS 23 0.0015
830 CATARACT 91 0.0015
831 PARAESTHESIA 240 0.0015
832 TINNITUS 70 0.0015
833 OESOPHAGEAL CARCINOMA 45 0.0015
834 RHINORRHOEA 98 0.0015
835 RASH MACULAR 53 0.0015
836 MUSCULOSKELETAL DISCOMFORT 26 0.0015
837 ANGER 51 0.0015
838 INJURY 106 0.0015
839 UNDERDOSE 110 0.0015
840 ROAD TRAFFIC ACCIDENT 63 0.0015
841 INSURANCE ISSUE 23 0.0015
842 PHARYNGEAL OEDEMA 23 0.0015
843 EAR PAIN 29 0.0015
844 LOCAL SWELLING 26 0.0015
845 PELVIC PAIN 27 0.0015
846 ANAPHYLACTIC REACTION 82 0.0015
847 ANHEDONIA 39 0.0015
848 LACTIC ACIDOSIS 48 0.0015
849 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 38 0.0015
850 HAEMORRHAGE 154 0.0015
851 MUSCULOSKELETAL DISORDER 28 0.0015
852 MYALGIA 248 0.0015
853 DEAFNESS 38 0.0015
854 PROCEDURAL PAIN 40 0.0014
855 VISUAL IMPAIRMENT 178 0.0014
856 ARRHYTHMIA 68 0.0014
857 LUNG NEOPLASM MALIGNANT 59 0.0014
858 DERMATITIS 30 0.0014
859 TYPE 2 DIABETES MELLITUS 48 0.0014
860 LYMPHOMA 22 0.0014
861 ABNORMAL DREAMS 39 0.0014
862 SUICIDAL IDEATION 129 0.0014
863 PANIC ATTACK 51 0.0014
864 CYANOSIS 22 0.0014
865 IRRITABILITY 84 0.0014
866 INTENTIONAL SELF-INJURY 28 0.0014
867 DRY SKIN 185 0.0014
868 PSYCHOMOTOR HYPERACTIVITY 23 0.0014
869 INFLUENZA 153 0.0014
870 WITHDRAWAL SYNDROME 57 0.0014
871 PRODUCT DOSE OMISSION ISSUE 399 0.0014
872 NERVOUSNESS 70 0.0013
873 ADVERSE DRUG REACTION 120 0.0013
874 DEVICE DISLOCATION 58 0.0013
875 ORAL HERPES 26 0.0013
876 NEOPLASM MALIGNANT 88 0.0013
877 MOOD SWINGS 42 0.0013
878 THROAT IRRITATION 59 0.0013
879 ALOPECIA 258 0.0013
880 ACCIDENTAL OVERDOSE 48 0.0013
881 FEELING ABNORMAL 314 0.0013
882 UNEVALUABLE EVENT 99 0.0013
883 DIABETES MELLITUS 99 0.0013
884 ERUCTATION 25 0.0013
885 NASOPHARYNGITIS 238 0.0013
886 BLOOD CHOLESTEROL INCREASED 60 0.0013
887 SKIN FISSURES 25 0.0013
888 PRURITUS 491 0.0013
889 BURNING SENSATION 89 0.0013
890 WEIGHT INCREASED 284 0.0013
891 DISCOMFORT 77 0.0013
892 FREQUENT BOWEL MOVEMENTS 34 0.0013
893 HEPATOTOXICITY 28 0.0013
894 MIGRAINE 120 0.0013
895 BLINDNESS 51 0.0013
896 INFLAMMATION 64 0.0012
897 CARDIAC DISORDER 116 0.0012
898 PRODUCT DOSE OMISSION IN ERROR 35 0.0012
899 KNEE ARTHROPLASTY 26 0.0012
900 DRUG ABUSE 102 0.0012
901 THROAT TIGHTNESS 33 0.0012
902 MYOCARDIAL INFARCTION 212 0.0012
903 TOOTH LOSS 25 0.0012
904 ECZEMA 63 0.0012
905 ARTHRITIS 94 0.0012
906 GASTRIC DISORDER 41 0.0012
907 CONJUNCTIVITIS 22 0.0012
908 NIGHTMARE 41 0.0012
909 LIVER INJURY 29 0.0012
910 VERTIGO 72 0.0012
911 BLOOD GLUCOSE INCREASED 221 0.0012
912 PRODUCT DOSE OMISSION 76 0.0012
913 FEELING HOT 71 0.0012
914 FEELING JITTERY 22 0.0012
915 FIBROMYALGIA 28 0.0012
916 INCREASED APPETITE 22 0.0012
917 PRODUCT DISPENSING ERROR 25 0.0011
918 PANCREATIC CARCINOMA 33 0.0011
919 INTENTIONAL PRODUCT USE ISSUE 100 0.0011
920 HYPOACUSIS 49 0.0011
921 MULTIPLE SCLEROSIS 54 0.0011
922 CRYING 41 0.0011
923 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
924 INCORRECT PRODUCT ADMINISTRATION DURATION 24 0.0011
925 ILLNESS 114 0.0011
926 CARDIOVASCULAR DISORDER 28 0.0011
927 PRODUCT USE IN UNAPPROVED INDICATION 269 0.0011
928 OCULAR HYPERAEMIA 51 0.0011
929 FLUSHING 108 0.0011
930 VISUAL ACUITY REDUCED 35 0.0011
931 ARTHROPATHY 58 0.0010
932 EMOTIONAL DISORDER 32 0.0010
933 OSTEONECROSIS 34 0.0010
934 MOOD ALTERED 28 0.0010
935 DRUG RESISTANCE 26 0.0010
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 182 0.0010
937 PHARMACEUTICAL PRODUCT COMPLAINT 26 0.0010
938 MULTIPLE SCLEROSIS RELAPSE 68 0.0010
939 SNEEZING 22 0.0010
940 SURGERY 56 0.0010
941 INFLUENZA LIKE ILLNESS 78 0.0009
942 GASTRIC CANCER 24 0.0009
943 ERECTILE DYSFUNCTION 24 0.0009
944 NERVOUS SYSTEM DISORDER 29 0.0009
945 INCORRECT DRUG ADMINISTRATION DURATION 26 0.0009
946 THERAPEUTIC PRODUCT EFFECT DECREASED 40 0.0009
947 WRONG TECHNIQUE IN DRUG USAGE PROCESS 32 0.0009
948 DEVICE ISSUE 79 0.0009
949 THERAPEUTIC RESPONSE DECREASED 53 0.0009
950 ILL-DEFINED DISORDER 53 0.0009
951 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 61 0.0009
952 EYE DISORDER 28 0.0009
953 DRUG INEFFECTIVE 1101 0.0008
954 THERAPEUTIC RESPONSE UNEXPECTED 37 0.0008
955 FEAR 22 0.0008
956 MATERNAL EXPOSURE DURING PREGNANCY 72 0.0008
957 ADVERSE EVENT 73 0.0008
958 DRUG DOSE OMISSION 130 0.0008
959 URTICARIA 130 0.0008
960 INTENTIONAL DOSE OMISSION 22 0.0008
961 BONE DENSITY DECREASED 24 0.0008
962 DRUG WITHDRAWAL SYNDROME 67 0.0008
963 DEVICE LEAKAGE 33 0.0008
964 EMOTIONAL DISTRESS 83 0.0007
965 EYE IRRITATION 39 0.0007
966 SUICIDE ATTEMPT 41 0.0007
967 INCORRECT DOSE ADMINISTERED 153 0.0007
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
969 PROSTATE CANCER 51 0.0006
970 DRUG EFFECT DECREASED 34 0.0006
971 VAGINAL HAEMORRHAGE 27 0.0006
972 MYELOSUPPRESSION 22 0.0006
973 INJECTION SITE MASS 22 0.0006
974 ACNE 45 0.0006
975 FOETAL EXPOSURE DURING PREGNANCY 46 0.0006
976 COMPLETED SUICIDE 45 0.0005
977 DISEASE RECURRENCE 24 0.0005
978 INTENTIONAL OVERDOSE 32 0.0005
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 98 0.0005
980 INJECTION SITE BRUISING 37 0.0005
981 PRODUCT QUALITY ISSUE 62 0.0005
982 PRODUCT SUBSTITUTION ISSUE 23 0.0004
983 DEVICE MALFUNCTION 26 0.0004
984 BREAST CANCER 33 0.0004
985 INJECTION SITE PAIN 104 0.0003
986 SKIN BURNING SENSATION 24 0.0003
987 INJECTION SITE PRURITUS 22 0.0003
988 INJECTION SITE HAEMORRHAGE 25 0.0003
989 DRUG DEPENDENCE 49 0.0003
990 INJECTION SITE ERYTHEMA 36 0.0003
991 INJECTION SITE SWELLING 22 0.0003
992 NO ADVERSE EVENT 50 0.0003